Tower Research Capital LLC (Trc) Allarity Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $5.8 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$0.22 - $31640.0 $425 - $61.3 Million
1,936 New
1,936 $1,000
Q1 2022

May 12, 2022
SELL
$1.93 - $10.75 $17 - $96
-9 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$9.1 - $12.62 $81 - $113
9 New
9 $0

Others Institutions Holding ALLR

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Allarity Therapeutics, Inc.

ALLR Quotes by TradingView
  • Ticker ALLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,260,200
  • Market Cap $14.1M
  • Description
  • Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; D...
More about ALLR
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email